WO1998051299A1 - Patchs contenant du nitrate d'isosorbide - Google Patents
Patchs contenant du nitrate d'isosorbide Download PDFInfo
- Publication number
- WO1998051299A1 WO1998051299A1 PCT/JP1998/002062 JP9802062W WO9851299A1 WO 1998051299 A1 WO1998051299 A1 WO 1998051299A1 JP 9802062 W JP9802062 W JP 9802062W WO 9851299 A1 WO9851299 A1 WO 9851299A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patch
- isosorbide dinitrate
- styrene
- adhesive
- isoprene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Definitions
- an object of the present invention is to provide an adhesive plaster containing styrene-isoprene-styrene block copolymer, rosin resin, liquid rubber, antioxidant, and oleic acid as essential components, and isosorbide dinitrate as a medicinal component.
- An object of the present invention is to provide an isosorbide dinitrate-containing patch characterized by containing it.
- the present invention relates to a solvent-based pressure-sensitive adhesive base containing styrene-isoprene-styrene block copolymer, rosin resin, liquid rubber, antioxidant, and oleic acid as essential components.
- Ethyl acetate solvent of isosorbide dinitrate coated on silicon-treated liner and dried Later, it is a patch containing isosorbide dinitrate bonded to a flexible support.
- the amount of styrene-isoprene-styrene block copolymer in the pressure-sensitive adhesive plaster (w / w%, the same in the following formulations) is used. Combined 15-35%, rosin resin 35-55%, liquefied rubber 5-20%, antioxidant 0.1-2%, and oleic acid 0.1-5% It is a patch containing isosorbide dinitrate.
- the adhesive plaster becomes hard and other This is not preferable because the decrease in the amount of the components makes it easy to precipitate crystals of isosorbide dinitrate.
- the rosin resin a hydrogenated rosin resin having a light color and a wide compatibility, excellent heat and oxidation stability is suitably used, and its blending amount in the adhesive plaster is 35 to 55%. Preferably, it is 40 to 50%.
- Antioxidants ensure stability during production and storage of adhesives PT JP98 / 02062
- oleic acid is used as an absorption enhancer, and its blending amount in the adhesive plaster is from 0.5 to 5%, preferably from 0.5 to 3%. If the compounding amount is less than 0.5%, the desired absorption promoting effect cannot be obtained, and if it exceeds 5%, the cohesive force of the pressure-sensitive adhesive decreases, and the absorption promoting effect more than 5% is observed. This is not preferred because it is not available.
- the amount of isosorbide dinitrate as a medicinal ingredient contained in the patch of the present invention is sufficient to obtain a desired therapeutic effect for ischemic disease as a result of percutaneous absorption of the active ingredient after application. Any amount may be used, specifically, 15 to 25% in the adhesive plaster.
- the amount is less than 15%, it is necessary to increase the amount of coating in order to obtain the amount of drug required for treatment, in which case the drying speed of the adhesive becomes slow, and the profitability in manufacturing process management Is not preferable because it deteriorates.
- the amount exceeds 25%, crystals of isosorbide dinitrate precipitate in the paste immediately after production, and the desired tackiness cannot be obtained, which is not preferable.
- the present invention is an isosorbide dinitrate-containing patch in which the content of isosorbide dinitrate is 15 to 25% in the adhesive plaster in the above case.
- the patch of the present invention is produced by the following method using each compounding component having the above-mentioned compounding amount.
- Table 3 summarizes the amount of isosorbide dinitrate permeated through the skin 24 hours after application of each test drug.
- Table 3 Rat skin permeation test results
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98919537A EP0968713B1 (en) | 1997-05-12 | 1998-05-11 | Plasters containing isosorbide nitrate |
CA002259584A CA2259584C (en) | 1997-05-12 | 1998-05-11 | Plasters containing isosorbide dinitrate |
DE69839800T DE69839800D1 (de) | 1997-05-12 | 1998-05-11 | Isosorbidnitrat enthaltentende pflaster |
AU72353/98A AU726537B2 (en) | 1997-05-12 | 1998-05-11 | Plasters containing isosorbide dinitrate |
US09/214,763 US6231884B1 (en) | 1997-05-12 | 1998-05-11 | Plasters containing isosorbide dinitrate |
HK00103498A HK1024173A1 (en) | 1997-05-12 | 2000-06-12 | Plasters containing isosorbide nitrate |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9/135751 | 1997-05-12 | ||
JP13575197A JP4136029B2 (ja) | 1997-05-12 | 1997-05-12 | 硝酸イソソルビド含有貼付剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998051299A1 true WO1998051299A1 (fr) | 1998-11-19 |
Family
ID=15159024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1998/002062 WO1998051299A1 (fr) | 1997-05-12 | 1998-05-11 | Patchs contenant du nitrate d'isosorbide |
Country Status (8)
Country | Link |
---|---|
US (1) | US6231884B1 (ja) |
EP (1) | EP0968713B1 (ja) |
JP (1) | JP4136029B2 (ja) |
AU (1) | AU726537B2 (ja) |
CA (1) | CA2259584C (ja) |
DE (1) | DE69839800D1 (ja) |
HK (1) | HK1024173A1 (ja) |
WO (1) | WO1998051299A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7235237B2 (en) | 1999-10-29 | 2007-06-26 | Nitromed, Inc. | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
US7708989B2 (en) | 1999-10-29 | 2010-05-04 | Nitromed, Inc. | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
WO2001035961A1 (en) * | 1999-10-29 | 2001-05-25 | Nitromed, Inc. | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
US7537785B2 (en) | 1999-10-29 | 2009-05-26 | Nitromed, Inc. | Composition for treating vascular diseases characterized by nitric oxide insufficiency |
CA2678256A1 (en) * | 2000-10-27 | 2002-05-02 | Nitromed Inc. | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
US20050181032A1 (en) * | 2002-06-25 | 2005-08-18 | Acrux Dds Pty Ltd. | Metastable pharmaceutical compositions |
CN102076340B (zh) * | 2008-06-27 | 2013-01-23 | 祐德药品工业株式会社 | 含芬太尼或其盐的经皮吸收型贴剂 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6036423A (ja) * | 1983-06-21 | 1985-02-25 | ザ、プロクタ−、エンド、ギヤンブル、カンパニ− | N−(2−ヒドロキシエチル)ピロリドンを含有する浸透局所製薬組成物 |
JPS63307818A (ja) * | 1987-06-08 | 1988-12-15 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
JPH0624969A (ja) * | 1992-07-09 | 1994-02-01 | Teikoku Seiyaku Co Ltd | ケトプロフェン含有外用貼付剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4994267A (en) * | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Transdermal acrylic multipolymer drug delivery system |
JP3202777B2 (ja) * | 1992-01-24 | 2001-08-27 | リンテック株式会社 | 経皮吸収促進剤及びテープ製剤 |
JP3523275B2 (ja) * | 1992-03-26 | 2004-04-26 | 東光薬品工業株式会社 | 貼付剤 |
US5725874A (en) * | 1993-05-19 | 1998-03-10 | Hisamitsu Pharmaceutical Co., Inc. | Solubilizer and external preparations containing the same |
-
1997
- 1997-05-12 JP JP13575197A patent/JP4136029B2/ja not_active Expired - Lifetime
-
1998
- 1998-05-11 DE DE69839800T patent/DE69839800D1/de not_active Expired - Lifetime
- 1998-05-11 AU AU72353/98A patent/AU726537B2/en not_active Ceased
- 1998-05-11 US US09/214,763 patent/US6231884B1/en not_active Expired - Fee Related
- 1998-05-11 CA CA002259584A patent/CA2259584C/en not_active Expired - Fee Related
- 1998-05-11 WO PCT/JP1998/002062 patent/WO1998051299A1/ja active IP Right Grant
- 1998-05-11 EP EP98919537A patent/EP0968713B1/en not_active Expired - Lifetime
-
2000
- 2000-06-12 HK HK00103498A patent/HK1024173A1/xx not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6036423A (ja) * | 1983-06-21 | 1985-02-25 | ザ、プロクタ−、エンド、ギヤンブル、カンパニ− | N−(2−ヒドロキシエチル)ピロリドンを含有する浸透局所製薬組成物 |
JPS63307818A (ja) * | 1987-06-08 | 1988-12-15 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
JPH0624969A (ja) * | 1992-07-09 | 1994-02-01 | Teikoku Seiyaku Co Ltd | ケトプロフェン含有外用貼付剤 |
Non-Patent Citations (1)
Title |
---|
See also references of EP0968713A4 * |
Also Published As
Publication number | Publication date |
---|---|
DE69839800D1 (de) | 2008-09-11 |
CA2259584A1 (en) | 1998-11-19 |
EP0968713A1 (en) | 2000-01-05 |
US6231884B1 (en) | 2001-05-15 |
AU726537B2 (en) | 2000-11-09 |
EP0968713A4 (en) | 2006-03-01 |
EP0968713B1 (en) | 2008-07-30 |
JP4136029B2 (ja) | 2008-08-20 |
JPH10310523A (ja) | 1998-11-24 |
AU7235398A (en) | 1998-12-08 |
HK1024173A1 (en) | 2000-10-05 |
CA2259584C (en) | 2008-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5243792B2 (ja) | 貼付剤 | |
NO303262B1 (no) | FremgangsmÕte for fremstilling av et faststoffmatrikssystem for transdermal medikamentavlevering | |
CA2525470C (en) | External patch containing estrogen and/or progestogen | |
NO309891B1 (no) | Transdermalt terapeutisk system og fremgangsmÕte for fremstilling derav | |
WO2002043729A1 (fr) | Timbres transdermiques analgesiques et anti-inflammatoires destines a un usage externe contenant de l'acide 4-biphenylylylacetique | |
JPH11228395A (ja) | 経皮吸収型製剤 | |
WO2006064747A1 (ja) | 医療用テープ剤 | |
KR20060086319A (ko) | 테이프 제제 | |
JPH08508238A (ja) | デクスパンテノールを含む、ステロイドホルモンの経皮的適用のための硬膏剤 | |
JP5546131B2 (ja) | 貼付剤、及び貼付剤の評価方法 | |
JPS63246327A (ja) | エトフエナマ−ト含有貼付薬 | |
WO2007077741A1 (ja) | 経皮吸収型製剤 | |
WO1998051299A1 (fr) | Patchs contenant du nitrate d'isosorbide | |
WO2016060122A1 (ja) | 貼付剤 | |
JP4008532B2 (ja) | 経皮吸収貼付製剤 | |
JP3144895B2 (ja) | 医療用粘着テープもしくはシート | |
JPH09291028A (ja) | 貼付剤 | |
JPH07309749A (ja) | フルルビプロフェン含有外用剤 | |
JP3184474B2 (ja) | 経皮吸収製剤 | |
JP5564241B2 (ja) | フェルビナク含有経皮吸収製剤 | |
JPH05310559A (ja) | 投錨性を向上させた貼付剤 | |
JPH05331064A (ja) | 消炎鎮痛貼付剤 | |
JPH07101864A (ja) | 経皮吸収貼付剤 | |
WO2002043711A1 (fr) | Preparation d'adhesif destine a l'usage externe | |
JP5677680B2 (ja) | 塩基性消炎鎮痛剤含有経皮吸収製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BE DE FR GB IT NL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 72353/98 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998919537 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2259584 Country of ref document: CA Ref country code: CA Ref document number: 2259584 Kind code of ref document: A Format of ref document f/p: F |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09214763 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1998919537 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 72353/98 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998919537 Country of ref document: EP |